Drug
Escitalopram
Escitalopram: highest development phase Post-Market, developed by Lundbeck, Lupin. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Lundbeck, Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Escitalopram NCT01430520 | Post-Market | Postoperative Pain |
| Escitalopram NCT00958633 | Phase 3 | Bipolar I Disorder |
| Escitalopram NCT00206934 | Not Applicable | Healthy Volunteers |
Latest
No recent events.
Follow Escitalopram on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.